A key epigenetic mechanism identified here was DNA methylation of HLA-A and HLA-A small focal deletions, typically in basal-like/TNBC metastatic disease, leading to lower expression of HLA-A and associated lowered expression of immune cell features. The gene discussed is HLA-A; the disease is metastatic neoplasm.